Infectious disease
Companies continue to report promising data for vaccines and therapies against COVID-19. Here’s a look.
Ocugen submitted a “Master File” to the U.S. FDA for COVAXIN, the vaccine that has already received authorization in India for people ages 12 and above.
The White House has also called for an independent investigation and more information from China about the pandemic’s origins.
Pfizer, Sagent Pharmaceuticals and Merck are preparing their antiviral pills against SARS-CoV-2 and are showing promise in new clinical trials.
The disclosure comes the day before the WHO is expected to plan for the next phase of investigations into the origins of COVID-19.
It was another busy week for clinical trial announcement. Here’s a look.
Researchers at John Hopkins made their preliminary conclusions that the vaccines produced by Pfizer-BioNTech and Moderna did not cause the hearing loss.
“The virus will not be eradicated through vaccination alone. That means... we need our medicines. That was a failure of 2020 that doesn’t get enough emphasis,” Jake Glanville, chief executive officer of Bay Area-based Centivax, told BioSpace in an interview.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
The House Select Subcommittee on the Coronavirus Crisis questioned executives from Emergent BioSolutions as part of a congressional probe.
PRESS RELEASES